Skip to main content
Log in

Cotrimoxazole prophylaxis worthy in Zambian kids with HIV

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ryan M, Griffin S, Chitah B, Walker AS, Mulenga V, Kalolo D, Hawkins N, Merry C, Barry MG, Chintu C, Sculpher MJ, Gibb DM.The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS 22: 749-757, No. 6, 30 Mar 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cotrimoxazole prophylaxis worthy in Zambian kids with HIV. Pharmacoecon. Outcomes News 553, 5 (2008). https://doi.org/10.2165/00151234-200805530-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805530-00008

Keywords

Navigation